Johnson & Johnson (JNJ)
155.50
+2.39
(+1.56%)
USD |
NYSE |
Nov 21, 16:00
155.05
-0.45
(-0.29%)
Pre-Market: 04:35
Johnson & Johnson Total Assets (Quarterly): 178.29B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 178.29B |
| June 30, 2024 | 181.09B |
| March 31, 2024 | 171.97B |
| December 31, 2023 | 167.56B |
| September 30, 2023 | 166.06B |
| June 30, 2023 | 191.69B |
| March 31, 2023 | 195.97B |
| December 31, 2022 | 187.38B |
| September 30, 2022 | 175.12B |
| June 30, 2022 | 177.72B |
| March 31, 2022 | 178.36B |
| December 31, 2021 | 182.02B |
| September 30, 2021 | 179.23B |
| June 30, 2021 | 176.44B |
| March 31, 2021 | 172.56B |
| December 31, 2020 | 174.89B |
| September 30, 2020 | 170.69B |
| June 30, 2020 | 158.38B |
| March 31, 2020 | 155.02B |
| December 31, 2019 | 157.73B |
| September 30, 2019 | 155.52B |
| June 30, 2019 | 155.12B |
| March 31, 2019 | 150.03B |
| December 31, 2018 | 152.95B |
| September 30, 2018 | 155.70B |
| Date | Value |
|---|---|
| June 30, 2018 | 155.36B |
| March 31, 2018 | 156.62B |
| December 31, 2017 | 157.30B |
| September 30, 2017 | 155.66B |
| June 30, 2017 | 152.81B |
| March 31, 2017 | 144.92B |
| December 31, 2016 | 141.21B |
| September 30, 2016 | 140.37B |
| June 30, 2016 | 139.81B |
| March 31, 2016 | 136.23B |
| December 31, 2015 | 133.41B |
| September 30, 2015 | 133.27B |
| June 30, 2015 | 132.04B |
| March 31, 2015 | 128.59B |
| December 31, 2014 | 130.36B |
| September 30, 2014 | 132.10B |
| June 30, 2014 | 135.20B |
| March 31, 2014 | 133.33B |
| December 31, 2013 | 132.68B |
| September 30, 2013 | 126.93B |
| June 30, 2013 | 124.32B |
| March 31, 2013 | 121.54B |
| December 31, 2012 | 121.35B |
| September 30, 2012 | 118.95B |
| June 30, 2012 | 115.75B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
155.02B
Minimum
Mar 2020
195.97B
Maximum
Mar 2023
174.91B
Average
175.78B
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Eli Lilly and Co | 75.61B |
| Merck & Co Inc | 117.53B |
| Pfizer Inc | 219.48B |
| AbbVie Inc | 143.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 108.13B |
| Shareholders Equity (Quarterly) | 70.16B |
| Debt to Equity Ratio | 0.5096 |
| Current Ratio | 1.029 |
| Net Debt Paydown Yield | 0.50% |